• Center on Health Equity & Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Healthcare Specialties Involved in Managing Patients With Chronic Spontaneous Urticaria 

Opinion
Video

A panel of experts discuss the healthcare specialties that become involved in treating patients with CSU.

Video content above is prompted by the following question(s):

  • Which healthcare specialties are involved in managing patients with CSU, and how can multidisciplinary care be optimized?
  • What are the comorbidities that are most seen in patients with CSU, and how do these affect your management plan?
Related Videos
4 Experts are featured in this series
4 Experts are featured in this series
4 Experts are featured in this series
4 Experts are featured in this series
Brigid Groves, PharmD, MS, vice president, professional affairs, American Pharmacists Association
5 Experts are featured in this series.
5 Experts are featured in this series.
5 experts in this video
Related Content
Chronic spontaneous urticaria was significantly associated with an increased risk of several predefined cardiovascular outcomes. | Image credit: inthasone - stock.adobe.com

Chronic Spontaneous Urticaria Linked to Increased Heart Disease Risk

October 30th 2025
Article

There is a significant link between chronic spontaneous urticaria and cardiovascular disease risk, highlighting the need for routine assessments.

Read More

Managed Care Cast Square thumbnail

Managed Care Cast Presents: Leveraging Topical Therapies for Pediatric Atopic Dermatitis

October 30th 2025
Podcast

Experts discuss how topical therapies effectively manage atopic dermatitis in pediatric patients, enhancing outcomes and addressing unique challenges.

Listen

Lungs | Image credit: Rasi - stock.adobe.com

Stereotactic Body Radiation Therapy Equally Effective as Surgery in Stage I NSCLC

October 30th 2025
Article

Comparable overall survival and distant recurrence outcomes make stereotactic body radiation a feasible alternative.

Read More

The Emerging Landscape of GLP-1 RA Therapies Across Conditions

The Emerging Landscape of GLP-1 RA Therapies Across Conditions

October 14th 2025
Podcast

The founder and President of Phesi addresses the need for streamlining clinical trial data as GLP-1 RA therapies are being used to treat multiple diseases.

Listen

Patients who adopt intensive lifestyle and risk factor modifications after ablation show improved long-term atrial rhythm stability. | Image Credit: Shapla - stock.adobe.com

Lifestyle Changes Reduce AF Recurrence After Ablation

October 30th 2025
Article

Aggressive lifestyle and risk factor control after ablation significantly lowers atrial fibrillation recurrence and improves heart health.

Read More

Group of young adults sitting down | Image credit: Drobot Dean - adobe.stock.com

Optimizing ALL Treatment Through Guideline Adherence and Highly-Effective Therapies

October 30th 2025
Article

Guideline adherence in treating acute lymphoblastic leukemia (ALL) enhances health care resource utilization, especially for adolescent and young adult patients.

Read More

© 2025 MJH Life Sciences
AJMC®
All rights reserved.